Academic Affairs and Networks

We are committed to scientific excellence and working with the best academic researchers towards the ultimate goal of improving health and making people feel better.

If you have a promising target compound or modelling system, that can make a difference in the substantial unmet need of neurodegenerative diseases and movement disorders, and would like to explore collaboration with Teva, we would love to hear from you.
 
Help your ideas to grow and plant the seeds of future therapies
Academic Affairs and Networks

What kind of collaborations are we looking for?

Novel assays and enabling technologies

  • New CNS target engagement assays
  • In vivo assays for BBB transport
  • Novel, high throughput in vivo assays for myelination/remyelination
  • Technologies that allow for the generation of antibodies against cell surface targets
  • Technologies for the generation of stable membrane protein preparations as antigens for monoclonal antibody development
  • Novel delivery methods through the Blood Brain barrier
  • Novel controlled release methods for CNS delivery

Novel disease models

  • New predictive animal models: for chronic pain, neurodegenerative disorders, movement disorders or respiratory disorders
  • IPSCs model systems and phenotypic assays for studying pain, neurodegenerative disorders and Movement disorders
  • Human pain models
  • Novel models for relapsing remitting and progressive MS
  • Digital assessment of rodent behavior

Novel targets and leads:

  • Novel target, lead compounds or antibody based treatments for
    • Neurodegenerative diseases including Huntington disease, Parkinson's disease, movement disorders and ALS.
    •  Pain (neuropathic, nociceptive and visceral pain), migraine and Headache (including migraine subtype, cluster headache and post traumatic headache)
  • Novel approaches for targeting respiratory disorders including COPD, cystic fibrosis and asthma

    Feel free to reach out to us at AAN@tevapharm.com

If your product is mature (<1 year from IND), we encourage you to also look at our business development opportunities here